Literature DB >> 27372873

CTC immune escape mediated by PD-L1.

Xuefei Wang1, Qiang Sun2, Qiaofei Liu1, Changjun Wang1, Ru Yao1, Yimin Wang1.   

Abstract

Breast cancer is the most common malignant tumor in women around the world. Most breast cancer-related deaths are from CTC (circulating tumor cells) metastasis. CTC is associated with the breast cancer patients' prognosis. But recently, circulating clusters were found and its metastasis and tumor formation ability is 23-50 times as CTC. However, its mechanism has not been clarified. These days, researchers have successfully completed CTC cluster separation, CTC cell culture, and PD-L1 was found to be related with histological grading of tumor. Meanwhile, the high expression of PD-L1 in CTC surface has also been reported. Since PD-L1 can mediate Treg to play the role of immunosuppression, we propose that CTC with positive PD-L1 is easier to connect PD-L1, immune cells (Treg regulatory T cells, MDSC bone marrow inhibitory cells) and CK cytokines etc. On one hand, Treg cells can protect CTC from being attacked by the immune system through the immunosuppression, on the other hand, they can weaken CTL killing ability and trigger more MDSC. Finally, CTC formed the metastatic lesion.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27372873     DOI: 10.1016/j.mehy.2016.05.022

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  21 in total

Review 1.  The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer.

Authors:  André Steven; Barbara Seliger
Journal:  Breast Care (Basel)       Date:  2018-02-02       Impact factor: 2.860

2.  Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies.

Authors:  Zhaoli Tan; Chunyan Yue; Shoujian Ji; Chuanhua Zhao; Ru Jia; Yun Zhang; Rongrui Liu; Da Li; Qian Yu; Ping Li; Zhiyuan Hu; Yanlian Yang; Jianming Xu
Journal:  Oncologist       Date:  2021-09-28

3.  Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression.

Authors:  Hong-Yu Zhang; Hong-Xia Liang; Shu-Huan Wu; He-Qing Jiang; Qin Wang; Zu-Jiang Yu
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

Review 4.  Mechanism of immune evasion in breast cancer.

Authors:  Mozhi Wang; Changwang Zhang; Yongxi Song; Zhenning Wang; Yaojia Wang; Fang Luo; Yujie Xu; Yi Zhao; Zhonghua Wu; Yingying Xu
Journal:  Onco Targets Ther       Date:  2017-03-14       Impact factor: 4.147

Review 5.  Human Cancer and Platelet Interaction, a Potential Therapeutic Target.

Authors:  Shike Wang; Zhenyu Li; Ren Xu
Journal:  Int J Mol Sci       Date:  2018-04-20       Impact factor: 5.923

Review 6.  Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer.

Authors:  Samarth Kansara; Vijay Pandey; Peter E Lobie; Gautam Sethi; Manoj Garg; Amit Kumar Pandey
Journal:  Cells       Date:  2020-06-21       Impact factor: 6.600

7.  A Collective Route to Head and Neck Cancer Metastasis.

Authors:  Arutha Kulasinghe; Henri Schmidt; Chris Perry; Bernard Whitfield; Liz Kenny; Colleen Nelson; Majid E Warkiani; Chamindie Punyadeera
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

8.  Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.

Authors:  Galatea Kallergi; Eleni-Kyriaki Vetsika; Despoina Aggouraki; Eleni Lagoudaki; Anastasios Koutsopoulos; Filippos Koinis; Panagiotis Katsarlinos; Maria Trypaki; Ippokratis Messaritakis; Christos Stournaras; Vassilis Georgoulias; Athanasios Kotsakis
Journal:  Ther Adv Med Oncol       Date:  2018-01-15       Impact factor: 8.168

9.  A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometry.

Authors:  Jinkai Teo; Anja Mirenska; Meihui Tan; Yifang Lee; Janice Oh; Lewis Z Hong; Richard Wnek; Yoon-Sim Yap; Shian-Jiun Shih; Ali Asgar S Bhagat; Chih-Liang Chin; David Ag Skibinski
Journal:  Future Sci OA       Date:  2017-09-04

10.  Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy.

Authors:  Chunyan Yue; Yubo Jiang; Ping Li; Yuehua Wang; Jian Xue; Nannan Li; Da Li; Ruina Wang; Yongjun Dang; Zhiyuan Hu; Yanlian Yang; Jianming Xu
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.